ARTIFICIAL INTELLIGENCE IN GYNECOLOGY AND WOMEN'S HEALTH: A NARRATIVE REVIEW OF CURRENT APPLICATIONS, CHALLENGES, AND FUTURE DIRECTIONS
Ghurki Journal of Medical and Health Sciences · 30.06.2026 · 2 (1) · 1-7
DOI: 10.71000/2axqez19 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ghurki Journal of Medical and Health Sciences, online erschienen am 30.06.2026. Verfasst von Dr Atiqa Ijaz und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Artificial intelligence (AI) is being used in more and more settings in obstetrics and gynecology, providing novel screening, diagnostic, treatment planning and monitoring solutions in women's health. AI tools can potentially address the gaps in service provision in low- and middle-income countries where medical access to specialist gynecologic and reproductive health care is not always available.
Objectives
To provide an update on the applications, benefits, limitations, and ethical implications of AI in gynecologic oncology, reproductive medicine, obstetric and gynecologic imaging, and gynecologic surgery.
Methods
A narrative literature review was conducted that incorporated structured data from PubMed, Scopus, and Google Scholar, and keywords included "artificial intelligence," "machine learning," "deep learning," "gynecology," "obstetrics," and "women's health," and combinations thereof, with the vast majority of searches occurring between 2020 and 2026. Key metrics were extracted from systematic reviews, meta-analyses and primary studies reporting quantitative diagnostic data (accuracy, sensitivity, specificity or area under the curve [AUC]).
Results
Twenty-one primary sources were included, representing over 150 individual primary sources. AI-enabled cervical cancer screening had an accuracy of up to 95% in 75 combined studies. The machine learning classifiers for PCOS diagnosis showed accuracy ranging from 89-100%, and AUC of 73-100% in 31 studies. The machine-learning model for the diagnosis of endometriosis had an AUC of 0.80 during validation. The pooled AUC of testing for the presence of PM in ovarian cancer was 0.81 for the radiomics-based models and 0.87 for the models that incorporated both clinical and radiomics-based data. Embryo-selection and IVF-outcome prediction models were more consistent than unaided visual grading, but prospective validation is still lacking.
Conclusion
AI has significant potential to enhance diagnostic precision, efficiency, and personalization of women's health care in the field of gynecology; however, its responsible use demands diverse training datasets, prospective validation, clear regulatory oversight, and careful efforts aimed at equity, particularly in low-resource countries like Pakistan. Keywords: Artificial Intelligence, Machine Learning, Gynecology, Women's Health, Reproductive Medicine, Gynecologic Oncology, Narrative Review.
Zitieren
APA
Ijaz, D. A., & Awan, D. F. N. (2026). ARTIFICIAL INTELLIGENCE IN GYNECOLOGY AND WOMEN'S HEALTH: A NARRATIVE REVIEW OF CURRENT APPLICATIONS, CHALLENGES, AND FUTURE DIRECTIONS. Ghurki Journal of Medical and Health Sciences, 2(1), 1-7. https://doi.org/10.71000/2axqez19
Vancouver
Ijaz DA, Awan DFN. ARTIFICIAL INTELLIGENCE IN GYNECOLOGY AND WOMEN'S HEALTH: A NARRATIVE REVIEW OF CURRENT APPLICATIONS, CHALLENGES, AND FUTURE DIRECTIONS. Ghurki Journal of Medical and Health Sciences. 2026;2(1):1-7. doi:10.71000/2axqez19
BibTeX
@article{Ijaz2026,
author = {Ijaz, Dr Atiqa and Awan, Dr Farah Niaz},
title = {ARTIFICIAL INTELLIGENCE IN GYNECOLOGY AND WOMEN'S HEALTH: A NARRATIVE REVIEW OF CURRENT APPLICATIONS, CHALLENGES, AND FUTURE DIRECTIONS},
journal = {Ghurki Journal of Medical and Health Sciences},
year = {2026},
volume = {2},
number = {1},
pages = {1--7},
doi = {10.71000/2axqez19}
}
EUVIMED